INS and Hypoglycemia: There was no difference between the two groups regarding the clinical and laboratory characteristics, including renal function, and initial parameters of InsulinAPP protocol, except for the highest initial total daily dose of insulin in the basal-bolus regimen in the group that had hypoglycemia ( P = 0.02).